HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Specific inhibition of histone deacetylase 8 reduces gene expression and production of proinflammatory cytokines in vitro and in vivo.

Abstract
ITF2357 (generic givinostat) is an orally active, hydroxamic-containing histone deacetylase (HDAC) inhibitor with broad anti-inflammatory properties, which has been used to treat children with systemic juvenile idiopathic arthritis. ITF2357 inhibits both Class I and II HDACs and reduces caspase-1 activity in human peripheral blood mononuclear cells and the secretion of IL-1β and other cytokines at 25-100 nm; at concentrations >200 nm, ITF2357 is toxic in vitro. ITF3056, an analog of ITF2357, inhibits only HDAC8 (IC50 of 285 nm). Here we compared the production of IL-1β, IL-1α, TNFα, and IL-6 by ITF2357 with that of ITF3056 in peripheral blood mononuclear cells stimulated with lipopolysaccharide (LPS), heat-killed Candida albicans, or anti-CD3/anti-CD28 antibodies. ITF3056 reduced LPS-induced cytokines from 100 to 1000 nm; at 1000 nm, the secretion of IL-1β was reduced by 76%, secretion of TNFα was reduced by 88%, and secretion of IL-6 was reduced by 61%. The intracellular levels of IL-1α were 30% lower. There was no evidence of cell toxicity at ITF3056 concentrations of 100-1000 nm. Gene expression of TNFα was markedly reduced (80%), whereas IL-6 gene expression was 40% lower. Although anti-CD3/28 and Candida stimulation of IL-1β and TNFα was modestly reduced, IFNγ production was 75% lower. Mechanistically, ITF3056 reduced the secretion of processed IL-1β independent of inhibition of caspase-1 activity; however, synthesis of the IL-1β precursor was reduced by 40% without significant decrease in IL-1β mRNA levels. In mice, ITF3056 reduced LPS-induced serum TNFα by 85% and reduced IL-1β by 88%. These data suggest that specific inhibition of HDAC8 results in reduced inflammation without cell toxicity.
AuthorsSuzhao Li, Gianluca Fossati, Carlo Marchetti, Daniela Modena, Pietro Pozzi, Leonid L Reznikov, Maria Luisa Moras, Tania Azam, Antonio Abbate, Paolo Mascagni, Charles A Dinarello
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 290 Issue 4 Pg. 2368-78 (Jan 23 2015) ISSN: 1083-351X [Electronic] United States
PMID25451941 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.
Chemical References
  • Cytokines
  • Histone Deacetylase Inhibitors
  • Interleukin-1alpha
  • Interleukin-1beta
  • Interleukin-6
  • Lipopolysaccharides
  • RNA, Messenger
  • Repressor Proteins
  • Tumor Necrosis Factor-alpha
  • Caspase 3
  • Caspase 7
  • Caspase 1
  • HDAC8 protein, human
  • Histone Deacetylases
Topics
  • Animals
  • Apoptosis
  • Candida (metabolism)
  • Caspase 1 (metabolism)
  • Caspase 3 (metabolism)
  • Caspase 7 (metabolism)
  • Cells, Cultured
  • Cytokines (metabolism)
  • Gene Expression Regulation, Enzymologic
  • Histone Deacetylase Inhibitors (chemistry)
  • Histone Deacetylases (metabolism)
  • Humans
  • Inflammation
  • Inhibitory Concentration 50
  • Interleukin-1alpha (metabolism)
  • Interleukin-1beta (metabolism)
  • Interleukin-6 (metabolism)
  • Leukocytes, Mononuclear (cytology, metabolism)
  • Lipopolysaccharides (chemistry)
  • Mice
  • Mice, Inbred C57BL
  • Monocytes (cytology)
  • RNA, Messenger (metabolism)
  • Real-Time Polymerase Chain Reaction
  • Repressor Proteins (antagonists & inhibitors, metabolism)
  • Tumor Necrosis Factor-alpha (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: